Untitled Document
Untitled Document

Home
Message From MD
About Us
Management Team
Our People
International Marketing
Product Profile
MediNews
Others
Contact Us
 
 

        

   
 
[Back]

Trade Name: ARIPRAZOLE TABLET 5 MG
Generic Name
: Ariprazole INN

Presentation:

Ariprazole 5 : Each film-coated tablet contains Aripiprazole INN 5 mg.
Ariprazole 10 : Each film-coated tablet contains Aripiprazole INN 10 mg.

Indications:

  • Schizophrenia

  • Acute manic & mixed episodes associated with bipolar disorder.

Dosage & Administration:

Schizophrenia: Usual recommended starting and target dose for aripiprazole is 10 to 15 mg/day administered on a once-a-day schedule without regared to meals. Aripiprazole has been shown to be effective in a dose range of 10 to 30 mg/day Maximum dosage increase should not be made befor 2 weeks.

Acute manic & mixed episodes associated with bipolar disorder:  Usal recommended starting dose is 30 mg given once a day. Does may be dereased to 15 mg based on assessment of tolerability.

Dosage adjustment are not routinely indicated on the basis of age, gender, race or renal or hepatic impairment status.

Cautions:

Aripiprazole should be used cautiously in patients at risk of orthostatic hypotension, seizure, patients for cognitive and motor impairment, dysphagia, suicide, in patients with concomitant illness, elderly, pregnancy.

Side effects:

Headache, asthenia, fever, nausea, vomiting, constipation, anxiety, insomnia, lightheadedness, somnolence, akathisia, tremor, rhinitis, coughing, rash, postural hypotension, dyspepsia and blurred vision. Neuroleptic malignant syndrome, tardive dyskinesia, hyperglycemia and diabetes mellitus have been rarely seen during aripiprazole therapy.

Contraindications:

Aripiprazole is contraindicated in patients with a known hypersensitivity to the product; child, adolescent & breast feeding mothers.

Drug interactions:

ketoconazole and quinidine increase the AUC of aripiprazole; so dose should be reduced by half when co-administered with these drug. Carbamazepine decreases the AUC of aripiprazole; so dose should be doubled while carbamazepine is co-administered.

Pregnancy and Lactation:

Aripiprazole should be used in pregnancy only if the potential benefits outweigh the potential risk to the fetus and it is recommended that women receiving aripiprazole should not breast-feed.

Commercial pack:

Ariprazole 5 : Each box contains 5 blister strips of 10 tablets.
Ariprazole 10 : Each box contains 3 blister strips of 10 tablets.

© 2006 General Pharmaceuticals Ltd. All rights reserved